Impact of prenatal estimation of the risk of respiratory distress in neonates with congenital pulmonary malformations on the choice of delivery site.


Journal

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie
ISSN: 1769-664X
Titre abrégé: Arch Pediatr
Pays: France
ID NLM: 9421356

Informations de publication

Date de publication:
May 2023
Historique:
received: 13 06 2022
revised: 07 11 2022
accepted: 04 03 2023
medline: 1 5 2023
pubmed: 16 4 2023
entrez: 15 4 2023
Statut: ppublish

Résumé

The vast majority of prenatally diagnosed congenital pulmonary malformations (CPM) remain asymptomatic at birth. The maximal value of the CPM volume ratio (CVRmax) predicts the risk of neonatal respiratory distress (NRD), and should allow for better assessment of the level of expertise needed at the delivery site. This study evaluated the level of maternity units currently chosen for the delivery of CPMs, and determined the impact of the choice of delivery site based on the CVRmax, with a threshold of 0.4 cm Data were extracted from the French prospective MALFPULM cohort, with inclusion between March 2015 and June 2018. The final study population consisted of 383 women. Deliveries in level 1 or 2 maternity units (n = 98, 25%) involved CPMs with lower CVRmax (p<0.001), causing fewer signs of prenatal compression (p = 0.025). Among the 62 children (16%) who presented with NRD, only seven (11%) were born in level 1 or 2 units (p = 0.0078). Choosing the maternity level according to the CVRmax would have increased the number of births in level 1 or 2 maternity hospitals by 70%. In these maternity units, the percentage of children with NRD would have increased from 8% in the actual distribution to 10% in the new strategy. Our results showed an overuse of level 3 maternity hospitals for the delivery of newborns with a prenatal diagnosis of CPM. The use of CVRmax should enable a reduction in the use of expertise centers without an adverse impact on newborns.

Sections du résumé

BACKGROUND BACKGROUND
The vast majority of prenatally diagnosed congenital pulmonary malformations (CPM) remain asymptomatic at birth. The maximal value of the CPM volume ratio (CVRmax) predicts the risk of neonatal respiratory distress (NRD), and should allow for better assessment of the level of expertise needed at the delivery site.
AIM OBJECTIVE
This study evaluated the level of maternity units currently chosen for the delivery of CPMs, and determined the impact of the choice of delivery site based on the CVRmax, with a threshold of 0.4 cm
METHODS METHODS
Data were extracted from the French prospective MALFPULM cohort, with inclusion between March 2015 and June 2018.
RESULTS RESULTS
The final study population consisted of 383 women. Deliveries in level 1 or 2 maternity units (n = 98, 25%) involved CPMs with lower CVRmax (p<0.001), causing fewer signs of prenatal compression (p = 0.025). Among the 62 children (16%) who presented with NRD, only seven (11%) were born in level 1 or 2 units (p = 0.0078). Choosing the maternity level according to the CVRmax would have increased the number of births in level 1 or 2 maternity hospitals by 70%. In these maternity units, the percentage of children with NRD would have increased from 8% in the actual distribution to 10% in the new strategy.
CONCLUSION CONCLUSIONS
Our results showed an overuse of level 3 maternity hospitals for the delivery of newborns with a prenatal diagnosis of CPM. The use of CVRmax should enable a reduction in the use of expertise centers without an adverse impact on newborns.

Identifiants

pubmed: 37061356
pii: S0929-693X(23)00052-0
doi: 10.1016/j.arcped.2023.03.004
pii:
doi:

Substances chimiques

4-chlorophenyl methyl sulfide 123-09-1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

195-200

Informations de copyright

Copyright © 2023 French Society of Pediatrics. Published by Elsevier Masson SAS. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

S Rovani (S)

AP-HP, Hôpital Necker-Enfants Malades, Service de Pneumologie et Allergologie Pédiatriques, Paris, France.

M Rahshenas (M)

Inserm UMR 1153, Maternité Port-Royal, Paris, France.

L J Salomon (LJ)

Université de Paris Cité, Paris, France; AP-HP, Hôpital Necker-Enfants Malades, Service d'Obstétrique, Paris, France.

A Benachi (A)

AP-HP, Hôpital Antoine Béclère, Service de Gynécologie-Obstétrique, Université Paris Sud, Clamart, France.

L Choupeaux (L)

AP-HP, Unité de recherche clinique Cochin-Necker, Paris, France.

V Goua (V)

Service d'Obstétrique, CHU Poitiers, France.

J-M Jouannic (JM)

AP-HP, Hôpital Armand-Trousseau, Service de Gynécologie-Obstétrique, Université Paris Sorbonne, France.

G Le Bouar (GL)

Service d'Obstétrique, CHU Rennes, France.

J Massardier (J)

Hospices Civils de Lyon, HFME, Service d'Obstétrique, France.

J Rosenblatt (J)

AP-HP, Hôpital Robert Debré, Service d'Obstétrique, Paris, France.

A Sartor (A)

Service d'Obstétrique, CHU Toulouse, France.

C Thong-Vanh (C)

Service d'Obstétrique, CHU Grenoble, France.

P Vaast (P)

Service d'Obstétrique, CRHU Lille, France.

N Lelong (N)

Inserm UMR 1153, Maternité Port-Royal, Paris, France.

B Khoshnood (B)

Inserm UMR 1153, Maternité Port-Royal, Paris, France.

C Delacourt (C)

AP-HP, Hôpital Necker-Enfants Malades, Service de Pneumologie et Allergologie Pédiatriques, Paris, France; Université de Paris Cité, Paris, France. Electronic address: christophe.delacourt@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH